Sentences with phrase «new diabetes treatments»

Not exact matches

With its established diabetes treatments in the firing line especially due to U.S. price pressures, Novo Nordisk needs to find new revenue lines that will be less sensitive to political pressures.

Sanofi, a diabetes specialist which is now facing increased competition from rivals, has been on a mission to boost its treatment pipeline with new products for diseases that affect a wide swath of patients.

Sørensen displaced last year's No. 1, Jeff Bezos of Amazon (who's now No. 87 thanks to HBR's new methodology), in part because his company made the decision to focus almost exclusively on diabetes treatment, which has driven up the company's sales and stock price.

April 24 U.S. drugmaker Eli Lilly and Co reported a quarterly profit on Tuesday on higher demand for its newer treatments such as its diabetes drug Trulicity and psoriasis medicine Taltz.

A new study sounds the alarm about Type 2 diabetes and treatment.

New York Governor Andrew Cuomo is on the verge of making medical marijuana legal in the state — a treatment that researchers are now saying may help control blood sugar and diabetes.

Stem cell research and diabetes Stem cell research is a relatively new area of investigation, believed by many in the scientific and medical communities to have important new potential for the treatment of many diseases and conditions particularly those like diabetes, which are characterised by severe damage to certain cells and tissues..

It is unacceptable for people with diabetes to be deprived of (new) developments because of «postcode prescribing» where access to treatment depends on where the individual lives or from whom they receive their diabetes care..

«Discovery of this mutation adds to the growing list of insights gained from genomic studies that can be used to develop new treatments and customize existing treatments for type 2 diabetes and related metabolic disorders,» Dr. Damcott says.

«New treatment options, better hope of preventing vision loss from diabetes.»

The team believes that whichever way BMP - 7 is used, it will be less risky than other treatments for type 1 diabetes that are currently being investigated, such as those that create pancreatic cells from stem cells, or by introducing new genes into the body.

Treatments based on hESCs for a whole range of conditions from diabetes to heart disease are also moving towards trials, as New Scientist reported last year.

«This is a very exciting finding, obtained by studying patients» cells, that has the potential to result in a new treatment for this chronic complication of longstanding Type 1 diabetes,» Dr. Folli said.

«Major study heralds new era in treatment of type 2 diabetes.»

MIT engineers hope to improve treatment for diabetes patients with a new type of engineered insulin.

The discoveries could lead to new treatments for diabetes or for people with wasting diseases, say Johan Auwerx of the Federal Polytechnic School of Lausanne, Switzerland, and colleagues.

British newspapers reported this weekend that Ian Wilmut, the University of Edinburgh biologist who led the team that in 1997 cloned Dolly the sheep, is getting out of the cloning business in light of the new findings, which seem to offer researchers a likely new source of stem cell lines for basic research that could one day lead to new treatments and perhaps cures for spinal injuries, diabetes and debilitating disorders such as multiple sclerosis and Parkinson's disease.

«Stem cells pave the way for new treatment of diabetes.»

«Discovery of new hormone opens doors to new type 2 diabetes treatments.»

Karsenty's findings could lead to new treatments for diabetes.

In addition to illuminating how the drug, amlexanox, reverses obesity, diabetes and fatty liver disease, the findings suggest a new pathway for future treatments.

This group's achievement will lead to the clarification of the mechanism behind the localization of GLUT4 and the mechanism for developing diabetes, as well as the development of new types of treatment drugs.

This single enzyme, they realized, could be a target for new treatments for diabetes and other diseases of obesity.

They might even point the way to new treatments for diabetes.

Knowing that inflammation improves insulin signaling rather than hindering it could usher in a new era for treatment of type 2 diabetes, one that targets molecules in the inflammatory pathway.

New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.

«This work validates a new potential target for the treatment of diabetes,» Liu said.

With the discovery of a compound that can slow the degradation of insulin in animals, scientists at Harvard have opened the door to a potential new treatment for diabetes.

«Discovery of compound may open new road to diabetes treatment.»

«Diabetes treatment: New strategy focuses on maintaining higher insulin levels.»

The discovery of an inhibitor of the Insulin Degrading Enzyme (IDE), a protein responsible for the susceptibility of diabetes because it destroys insulin in the body, may lead to new treatment approaches for diabetes.

«Diabetes more frequent in children with chronic rheumatic disease: Further research into link between Type 1 diabetes and Juvenile Inflammatory Arthritis may lead to new treatmentsDiabetes more frequent in children with chronic rheumatic disease: Further research into link between Type 1 diabetes and Juvenile Inflammatory Arthritis may lead to new treatmentsdiabetes and Juvenile Inflammatory Arthritis may lead to new treatments.»

Resistin has been mapped to the pathway of immune - mediated inflammation that promotes diabetes and other obesity - related disorders and Nair hopes to combine her lab's basic science expertise with the developing clinical research enterprise in the UCR medical school as a future avenue to research new diagnostic or treatment strategies.

Researchers have developed a «global human metabolic network» that could pave the way for new treatments aimed at disorders like diabetes and high cholesterol

Technique could be used in new treatments for Parkinson's disease, diabetes, multiple sclerosis

Theoretically, such stem cells can form any of the body's cell types and could be used in new treatments for Parkinson's disease, diabetes, multiple sclerosis, cardiac disease, and spinal cord injuries.

We believe that this new information on the structure of the adiponectin receptors will help us understand new relationships between the structure and functions of these important receptors, which we know to be evolutionarily conserved, and hopefully will contribute to the development of new adiponectin receptor agonists that can be used for the treatment of obesity - related diseases such as type 2 diabetes.

Wells and his colleagues have a particular interest in finding new treatments for genetic forms of diseases like monogenic diabetes and Hirschsprung's disease.

The work may also lead to new treatments for diseases such as diabetes.

Publication of the Diabetes Update coincided with the recent approval from the US Food and Drug Administration of a new dapagliflozin from AstraZeneca and Bristol - Myers Squibb for the treatment of adults with type 2 dDiabetes Update coincided with the recent approval from the US Food and Drug Administration of a new dapagliflozin from AstraZeneca and Bristol - Myers Squibb for the treatment of adults with type 2 diabetesdiabetes.

While the study did not support earlier findings that sitagliptin was an effective treatment for NAFLD, Loomba said it provided new evidence that clinical trials with patients at higher risk of diabetes do not necessarily need a liver biopsy to be efficiently screened for potential therapeutic agents.

But the new study firmly establishes that some of these cells endure for many decades in some Medalists — offering clues to potential treatments for preserving and even restoring the crucial cell population, says George L. King, M.D., senior author on the paper, Joslin's chief scientific officer and head of the Dianne Nunnally Hoppes Laboratory for Diabetes Complications.

«We will be moving promptly to use this important progress in our understanding of the molecular pathology of stroke and late - onset diabetes to develop new products for better diagnosis, treatment and prevention of these diseases, thus translating this new knowledge as quickly as possible into benefits for patients and their families.»

New research in SCTM describes a safe and effective new strategy for the treatment of type 1 diabetes using induced pluripotent stem cell - derived progenitNew research in SCTM describes a safe and effective new strategy for the treatment of type 1 diabetes using induced pluripotent stem cell - derived progenitnew strategy for the treatment of type 1 diabetes using induced pluripotent stem cell - derived progenitors

These centers focus the efforts of collaborative groups of researchers on defined areas of inquiry, to accelerate progress toward the development of new treatments and vaccines to prevent and cure type 1 diabetes, cancer and infectious disease.

The ability to edit RNA in human cells opens up an entirely new world of disease treatments targeting conditions including diabetes and IBD.

The acquisition of this knowledge will be essential to develop new treatments against developmental disorders and could also help understand adult diseases such as diabetes that may originate during the early stage of life.

Michigan Medicine and MedImmune, the global biologics research and development arm of AstraZeneca (NYSE: AZN), have entered into a three - year research alliance to identify potential new therapies for the prevention and treatment of diabetes, obesity and related metabolic disorders.

Its scientists carry out research seeking new knowledge leading to the prevention of disease through vaccines and the treatment and cure of infectious diseases, cancer, inflammatory and autoimmune diseases such as rheumatoid arthritis, type 1 (juvenile) diabetes, Crohn's disease and asthma.

7/8/2008 Liver Protein Associated with Type 2 Diabetes in Older Adults Study may indicate novel targets for prevention or treatment The presence of a protein expressed by the liver which inhibits insulin action may identify individuals more likely to develop type 2 diabetes, according to a new study led by a researcher...Diabetes in Older Adults Study may indicate novel targets for prevention or treatment The presence of a protein expressed by the liver which inhibits insulin action may identify individuals more likely to develop type 2 diabetes, according to a new study led by a researcher...diabetes, according to a new study led by a researcher... More...